Structural Entry Filters:

Search Count: 44

Download
9OB2 image
Cdk2/Cycline Bound To Compound 11 With P-Loop In The Ee And Cc Conformations

9OB3 image
Cdk2/Cycline Bound To Compound 16 With P-Loop In The Ee Conformation

9OB4 image
Cdk2/Cycline Bound To Compound 19 With P-Loop In The Ee And Ec Conformations

9OB5 image
Cdk2/Cycline Bound To Compound 20 With P-Loop In The Ee And Cc Conformations

9OB6 image
Cdk2/Cycline Bound To Compound 21 With P-Loop In The Ee And Cc Conformations

8SWE image
Fgfr2 Kinase Domain Bound To Reversible Inhibitor Cmpd 3
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.24 Å Release Date: 2024-02-14
Classification: ONCOPROTEIN
Ligands: GOL, GSH, WXQ

8U1F image
Fgfr2 Kinase Domain Bound To Irreversible Inhibitor Cmpd 10

8T6D image
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.40 Å Release Date: 2023-10-11
Classification: HYDROLASE
Ligands: SO4, YR2

8T6G image
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.84 Å Release Date: 2023-10-11
Classification: HYDROLASE
Ligands: SO4, YT2

8T7Q image
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:2.10 Å Release Date: 2023-10-11
Classification: HYDROLASE
Ligands: ZH5

8T8Q image
Identification Of Gdc-1971 (Rly-1971), A Shp2 Inhibitor Designed For The Treatment Of Solid Tumors

8STG image
Discovery And Clinical Validation Of Rly-4008, The First Highly Selective Fgfr2 Inhibitor With Activity Across Fgfr2 Alterations And Resistance Mutations

7TAB image
G-925 Bound To The Smarca4 (Brg1) Bromodomain

7TD9 image
G-059 Bound To The Smarca4 (Brg1) Bromodomain

6DF7 image
Taf1-Bd2 In Complex With Cpd27 (6-(But-3-En-1-Yl)-4-(1-Methyl-6-(Morpholine-4-Carbonyl)-1H-Benzo[D]Imidazol-4-Yl)-1,6-Dihydro-7H-Pyrrolo[2,3-C]Pyridin-7-One)

6DF4 image
Taf1-Bd2 In Complex With Cpd8 (6-(But-3-En-1-Yl)-4-(3-(Morpholine-4-Carbonyl)Phenyl)-1,6-Dihydro-7H-Pyrrolo[2,3-C]Pyridin-7-One)

5W0F image
Crebbp Bromodomain In Complex With Cpd3 ((S)-1-(3-(6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydrofuran-3-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)

5W0I image
Crebbp Bromodomain In Complex With Cpd8 (1-(3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydrofuran-3-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)

5W0L image
Crebbp Bromodomain In Complex With Cpd10 (1-(3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydro-2H-Pyran-4-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)

5W0Q image
Crebbp Bromodomain In Complex With Cpd17 (N,2,7-Trimethyl-2,3-Dihydro-4H-Benzo[B][1,4]Oxazine-4-Carboxamide)
Protein Functional Filters:
Feedback Form
Name
Email
Institute
Feedback